Almirall and Microsoft: A Strategic Partnership to Revolutionize the Dermatological Landscape

Almirall and Microsoft: A Strategic Partnership to Revolutionize the Dermatological Landscape

Almirall, a global pharmaceutical leader in medical dermatology, and Microsoft, a technology giant, have announced an exciting collaboration aimed at driving innovation and digital transformation within Almirall. This partnership is set to pioneer the development of new-generation personalized treatments for skin conditions.

A Three-Year Collaboration for Technological Innovation

The three-year collaboration between Almirall and Microsoft aims to expedite Almirall’s digitalization and technological innovation. The primary focus will be to improve Almirall’s current unified data platform and fuel digital innovation in the discovery and development of new drugs. This will tackle unmet needs in medical dermatology through the application of generative AI and other advanced analytical technologies.

Harnessing AI for Rapid Analysis and Drug Discovery

Almirall plans to utilize generative AI to swiftly analyze extensive datasets, fostering a patient-centric and agile digital culture. In R&D, the goal is to fast-track the discovery of new therapeutic targets and employ generative AI and advanced analytical technologies to uncover synthesizable molecules. This approach is expected to propel the growth of Almirall’s product pipeline.

Optimizing Operations through Data and AI

This partnership also aims to enhance operations through data and AI, building a technology platform based on intelligence. AI technologies will be used to prioritize drug discovery based on their innovation level and commercialization potential before their validation.

Enhancing Almirall’s Data Governance and Digital Environment

During the collaboration, Almirall will establish a new data management model, supported by technology, to optimize access to high-quality data. This includes data governance, quality processes, and digital identity management, among other things. Almirall aims to foster collaboration with a high security level while driving digital innovation in drug discovery and development.

Carlos Gallardo, CEO of Almirall, expressed, “At Almirall, we believe that true innovation stems from collaboration with distinguished experts and a willingness to be at the forefront of science and technology.

The agreement with Microsoft is a significant step forward in our journey to offer novel treatments to patients. It will allow us to leverage the latest technologies to transform our way of working and accelerate drug discovery.”

About Almirall

Almirall is a global pharmaceutical company dedicated to medical dermatology. They work closely with leading scientists, healthcare professionals, and patients to fulfill their purpose: “Transforming the patients’ world, helping them to realize their hopes and dreams of a healthy life”. Almirall is at the forefront of science to offer pioneering and differentiated innovations in medical dermatology that respond to the needs of the patients.

Microsoft reinforces its commitment to digital sovereignty

Microsoft Ibérica has announced its commitment to ensure that Spanish customers’ data is stored and processed within the EU, aligning with its EU Data Boundary initiative.

SANTALUCÍA signs a collaboration agreement with Microsoft to boost its digital transformation and innovation

SANTALUCÍA and Microsoft have established a strategic alliance to drive the insurer’s digitalization. The implementation of Microsoft Azure’s AI aims to automate processes, optimize functions in IT and cybersecurity areas, and improve productivity in the SANTALUCÍA GROUP.

Hospital Sant Joan de Déu Barcelona and Microsoft collaborate in creating an AI Laboratory for the development of digital health projects

The two entities will analyze the joint development of use cases and projects focused on digital health with the application of Generative Artificial Intelligence, such as the launch of an AI for Health – AI Health Copilot Lab.

Valdecilla Hospital bets on Microsoft Azure and HoloLens 2 to integrate mixed reality in surgical planning

The virtual Valdecilla Hospital and the Marqués de Valdecilla University Hospital have created LINA, a mixed reality-based platform that facilitates the planning of complex clinical procedures and the collaboration between doctors worldwide.


This collaboration between Almirall and Microsoft is a significant step forward in the medical dermatology field. By combining Almirall’s deep knowledge and experience in R&D and drug discovery with Microsoft’s cutting-edge technologies, the partnership promises to revolutionize the way we understand and treat skin diseases.

Time will tell the extent of this revolution, but one thing is certain: the future of dermatology is digital.